Publication Date:
1989-08-04
Description:
〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Lewin, R -- New York, N.Y. -- Science. 1989 Aug 4;245(4917):467-8.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/2502841" target="_blank"〉PubMed〈/a〉
Keywords:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
;
Clinical Trials as Topic
;
Designer Drugs
;
Humans
;
Levodopa/therapeutic use
;
Monoamine Oxidase Inhibitors/*therapeutic use
;
Neurons/physiology
;
Parkinson Disease/*drug therapy
;
Parkinson Disease, Secondary/chemically induced
;
Phenethylamines/*therapeutic use
;
Pyridines/adverse effects/metabolism
;
Selegiline/*therapeutic use
;
Substantia Nigra/pathology/physiopathology
Print ISSN:
0036-8075
Electronic ISSN:
1095-9203
Topics:
Biology
,
Chemistry and Pharmacology
,
Computer Science
,
Medicine
,
Natural Sciences in General
,
Physics